ANTI-PD-L1/IL-15 KD033 ACTIVATED MACROPHAGES AND INDUCED ANTI-TUMOR IMMUNITY IN THE TUMOR-MICROENVIRONMENT

被引:0
作者
Martomo, Stella [1 ]
Wang, George [1 ]
Polonskaya, Zhanna [1 ]
Luna, Xenia [1 ]
Lu, Dan [1 ]
Patel, Jeegar [1 ]
机构
[1] Kadmon Corp, New York, NY USA
关键词
D O I
10.1136/jitc-2021-SITC2021.652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
652
引用
收藏
页码:A681 / A681
页数:1
相关论文
共 50 条
[21]   Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo [J].
Li, Maohua ;
Zhao, Rongqing ;
Chen, Jianxin ;
Tian, Wenzhi ;
Xia, Chenxi ;
Liu, Xudong ;
Li, Yingzi ;
Li, Song ;
Sun, Hunter ;
Shen, Tong ;
Ren, Wenlin ;
Sun, Le .
SCIENTIFIC REPORTS, 2021, 11 (01)
[22]   Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity [J].
Guo, Jingya ;
Liang, Yong ;
Xue, Diyuan ;
Shen, Jiao ;
Cai, Yueqi ;
Zhu, Jiankun ;
Fu, Yang-Xin ;
Peng, Hua .
CELL RESEARCH, 2021, 31 (11) :1190-1198
[23]   Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity [J].
Jingya Guo ;
Yong Liang ;
Diyuan Xue ;
Jiao Shen ;
Yueqi Cai ;
Jiankun Zhu ;
Yang-Xin Fu ;
Hua Peng .
Cell Research, 2021, 31 :1190-1198
[24]   Tracking fluorescently labeled IL-15 and anti-PD-1 in the tumor microenvironment and draining lymph nodes [J].
Reyes, Anjelica F. ;
Goldusky, Josef ;
Bhimalli, Pavan ;
Marzo, Amanda L. ;
Schneider, Jeffrey R. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2022, 505
[25]   MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer [J].
Yi, Ruibin ;
Hong, Shuo ;
Zhang, Yueming ;
Lin, Anqi ;
Ying, Haoxuan ;
Zou, Weidong ;
Wang, Qiongyao ;
Wei, Ting ;
Cheng, Quan ;
Zhu, Weiliang ;
Luo, Peng ;
Zhang, Jian .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[26]   A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity [J].
Shi, Wenqiang ;
Lv, Liangyin ;
Liu, Nan ;
Wang, Hui ;
Wang, Yang ;
Zhu, Wen ;
Liu, Zexin ;
Zhu, Jianwei ;
Lu, Huili .
MOLECULAR THERAPY, 2023, 31 (01) :66-77
[27]   Acidic tumor microenvironment-activated MRI nanoprobes for modulation and visualization of anti-PD-L1 immunotherapy [J].
Fan, Kai ;
Yang, Xue ;
Tian, Fang-zheng ;
Li, Si-yu ;
Zhang, Jian-qiong ;
Xie, Jin-bing ;
Ju, Sheng-hong .
NANO TODAY, 2024, 54
[28]   Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist [J].
Knudson, Karin M. ;
Hicks, Kristin C. ;
Ozawa, Yohei ;
Schlom, Jeffrey ;
Gameiro, Sofia R. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[29]   Remodeling of the Tumor Microenvironment by a Chemokine/Anti-PD-L1 Nanobody Fusion Protein [J].
Fang, Tao ;
Li, Ran ;
Li, Zeyang ;
Cho, Julia ;
Guzman, Jonathan S. ;
Kamm, Roger D. ;
Ploegh, Hidde L. .
MOLECULAR PHARMACEUTICS, 2019, 16 (06) :2838-2844
[30]   Preparation and anti-tumor ability evaluation of anti-PD-L1 conjugated curcumin in colon cancer [J].
Ding, Jie ;
Liu, Zhenhua ;
Liu, Sheng ;
Xie, Xueqing ;
Yin, Qingling ;
Lu, Wei ;
Wang, Wanchuan ;
Zhang, Yi .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 306